Oxidative stress and suicidal erythrocyte death

Antioxidants and Redox Signaling

Volumn 21, Issue 1, 2014, Pages 138-153

  Lang, Florian ^a   Abed, Majed ^a   Lang, Elisabeth ^a   Föller, Michael ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; CALCIUM CHANNEL; CALPAIN; CASEIN KINASE IALPHA; CASPASE; CERAMIDE; CYCLIC GMP DEPENDENT PROTEIN KINASE; ERYTHROPOIETIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; JANUS KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; P21 ACTIVATED KINASE 2; PHOSPHOLIPASE A2; POTASSIUM CHANNEL; PROSTAGLANDIN E2; SPHINGOMYELIN PHOSPHODIESTERASE; THROMBOCYTE ACTIVATING FACTOR; CALCIUM;

ARTICLE; CELL DEATH; CELL MEMBRANE; CHRONIC KIDNEY DISEASE; CYTOSKELETON; DIABETES MELLITUS; ENZYME ACTIVATION; ERYPTOSIS; ERYTHROCYTE; HUMAN; IRON DEFICIENCY; MALARIA; MOLECULE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; SEPSIS; SICKLE CELL ANEMIA; THALASSEMIA; WILSON DISEASE; ANIMAL; CYTOLOGY; GENETICS; METABOLISM; PHYSIOLOGY;

ANIMALS; CALCIUM; CELL DEATH; ERYTHROCYTES; HUMANS; OXIDATIVE STRESS;

EID: 84902186043     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2013.5747     Document Type: Article

References (200)

1. Abed M, Towhid ST, Mia S, Pakladok T, Alesutan I, Borst O, Gawaz M, Gulbins E, and Lang F. Sphingomyelinase- induced adhesion of eryptotic erythrocytes to endothelial cells. Am J Physiol Cell Physiol 303: C991-C999, 2012.
2. Abed M, Towhid ST, Shaik N, and Lang F. Stimulation of suicidal death of erythrocytes by rifampicin. Toxicology 302: 123-128, 2012.
3. Adamson JW. Hyporesponsiveness to erythropoiesis stimulating agents in chronic kidney disease: the many faces of inflammation. Adv Chronic Kidney Dis 16: 76-82, 2009.
4. Agar NS, Sadrzadeh SMH, Hallaway PE, and Eaton JW. Erythrocyte catalase-a somatic oxidant defense. J Clin Invest 77: 319-321, 1986.
5. Ahmed MS, Langer H, Abed M, Voelkl J, and Lang F. The uremic toxin acrolein promotes suicidal erythrocyte death. Kidney Blood Press Res 37: 158-167, 2013.
6. Andrews DA and Low PS. Role of red blood cells in thrombosis. Curr Opin Hematol 6: 76-82, 1999.
7. Antonelou MH, Kriebardis AG, Velentzas AD, Kokkalis AC, Georgakopoulou SC, and Papassideri IS. Oxidative stress-associated shape transformation and membrane proteome remodeling in erythrocytes of end stage renal disease patients on hemodialysis. J Proteom 74: 2441-2452, 2011.
8. Arese P, Turrini F, and Schwarzer E. Band 3/complementmediated recognition and removal of normally senescent and pathological human erythrocytes. Cell Physiol Biochem 16: 133-146, 2005.
9. Arruda MM, Mecabo G, Rodrigues CA, Matsuda SS, Rabelo IB, and Figueiredo MS. Antioxidant vitamins C and E supplementation increases markers of haemolysis in sickle cell anaemia patients: a randomized, double-blind, placebocontrolled trial. Br J Haematol 160: 688-700, 2013.
10. Atkinson MA and Furth SL. Anemia in children with chronic kidney disease. Nat Rev Nephrol 7: 635-641, 2011.
11. Attanasio P, Ronco C, Anker SD, Cicoira M, and von Haehling S. Role of iron deficiency and anemia in cardiorenal syndromes. Semin Nephrol 32: 57-62, 2012.
12. Attri S, Sharma N, Jahagirdar S, Thapa BRT, and Prasad R. Erythrocyte metabolism and antioxidant status of patients with Wilson disease with hemolytic anemia. Pediatric Res 59: 593-597, 2006.
13. Awasthi YC, Beutler E, and Srivastava SK. Purification and Properties of Human Erythrocyte Glutathione Peroxidase. J Biol Chem 250: 5144-5149, 1975.
14. Ayi K, Giribaldi G, Skorokhod A, Schwarzer E, Prendergast PT, and Arese P. 16alpha-bromoepiandrosterone, an antimalarial analogue of the hormone dehydroepiandrosterone, enhances phagocytosis of ring stage parasitized erythrocytes: a novel mechanism for antimalarial activity. Antimicrob Agents Chemother 46: 3180-3184, 2002.
15. Ayi K, Turrini F, Piga A, and Arese P. Enhanced phagocytosis of ring-parasitized mutant erythrocytes: a common mechanism that may explain protection against falciparum malaria in sickle trait and beta-thalassemia trait. Blood 104: 3364-3371, 2004.
16. Bandeira SD, Guedes GD, da Fonseca LJS, Pires AS, Gelain DP, Moreira JCF, Rabelo LA, Vasconcelos SML, and Goulart MOF. Characterization of blood oxidative stress in type 2 diabetes mellitus patients: increase in lipid peroxidation and SOD activity. Oxid Med Cell Longev 2012: 819310, 2012.
17. Barvitenko NN, Adragna NC, and Weber RE. Erythrocyte signal transduction pathways, their oxygenation dependence and functional significance. Cell Physiol Biochem 15: 1-18, 2005.
18. Basu S, Banerjee D, Chandra S, and Chakrabarti A. Loss of phospholipid membrane asymmetry and sialylated glycoconjugates from erythrocyte surface in haemoglobin E beta-thalassaemia. Br J Haematol 141: 92-99, 2008.
19. Bell SG. An introduction to hemoglobin physiology. Neonatal Netw 18: 9-15, 1999.
20. Benhar M and Stamler JS. A central role for S-nitrosylation in apoptosis. Nature Cell Biol 7: 645-646, 2005.
21. Berg CP, Engels IH, Rothbart A, Lauber K, Renz A, Schlosser SF, Schulze-Osthoff K, and Wesselborg S. Human mature red blood cells express caspase-3 and caspase-8, but are devoid of mitochondrial regulators of apoptosis. Cell Death Differ 8: 1197-1206, 2001.
22. Besarab A and Coyne DW. Iron supplementation to treat anemia in patients with chronic kidney disease. Nat Rev Nephrol 6: 699-710, 2010.
23. Betal SG and Setty BNY. Phosphatidylserine-positive erythrocytes bind to immobilized and soluble thrombospondin- 1 via its heparin-binding domain. Translat Res 152: 165-177, 2008.
24. Bhavsar SK, Gu S, Bobbala D, and Lang F. Janus kinase 3 is expressed in erythrocytes, phosphorylated upon energy depletion and involved in the regulation of suicidal erythrocyte death. Cell Physiol Biochem 27: 547-556, 2011.
25. Bilmen S, Aksu TA, Gumuslu S, Korgun DK, and Canatan D. Antioxidant capacity of G-6-PD-deficient erythrocytes. Clin Chim Acta 303: 83-86, 2001.
26. Bookchin RM, Ortiz OE, and Lew VL. Activation of calcium-dependent potassium channels in deoxygenated sickled red cells. Prog Clin Biol Res 240: 193-200, 1987.
27. Borst O, Abed M, Alesutan I, Towhid ST, Qadri SM, Foller M, Gawaz M, and Lang F. Dynamic adhesion of eryptotic erythrocytes to endothelial cells via CXCL16/ SR-PSOX. Am J Physiol Cell Physiol 302: C644-C651, 2012.
28. Bosman GJ, Willekens FL, and Werre JM. Erythrocyte aging: a more than superficial resemblance to apoptosis? Cell Physiol Biochem 16: 1-8, 2005.
29. Bottger E, Multhoff G, Kun JF, and Esen M. Plasmodium falciparum-infected erythrocytes induce granzyme B by NK cells through expression of host-Hsp70. PLoS One 7: e33774, 2012.
30. Bracci R, Perrone S, and Buonocore G. Oxidant injury in neonatal erythrocytes during the perinatal period. Acta Paediatr Suppl 91: 130-134, 2002.
31. Brand VB, Sandu CD, Duranton C, Tanneur V, Lang KS, Huber SM, and Lang F. Dependence of Plasmodium falciparum in vitro growth on the cation permeability of the human host erythrocyte. Cell Physiol Biochem 13: 347-356, 2003.
32. Bratosin D, Estaquier J, Petit F, Arnoult D, Quatannens B, Tissier JP, Slomianny C, Sartiaux C, Alonso C, Huart JJ, Montreuil J, and Ameisen JC. Programmed cell death in mature erythrocytes: a model for investigating death effector pathways operating in the absence of mitochondria. Cell Death Differ 8: 1143-1156, 2001.
33. Brugnara C, de Franceschi L, and Alper SL. Inhibition of Ca(2 + )-dependent K+ transport and cell dehydration in sickle erythrocytes by clotrimazole and other imidazole derivatives. J Clin Invest 92: 520-526, 1993.
34. Bruha R, Vitek L, Marecek Z, Pospisilova L, Nevsimalova S, Martasek P, Petrtyl J, Urbanek P, Jiraskova A, Malikova I, Haluzik M, and Ferenci P. Decreased serum antioxidant capacity in patients with Wilson disease is associated with neurological symptoms. J Inherited Metabol Dis 35: 541-548, 2012.
35. Calderon-Salinas JV, Munoz-Reyes EG, Guerrero-Romero JF, Rodriguez-Moran M, Bracho-Riquelme RL, Carrera-Gracia MA, and Quintanar-Escorza MA. Eryptosis and oxidative damage in type 2 diabetic mellitus patients with chronic kidney disease. Mol Cell Biochem 357: 171-179, 2011.
36. Cappadoro M, Giribaldi G, O'Brien E, Turrini F, Mannu F, Ulliers D, Simula G, Luzzatto L, and Arese P. Early phagocytosis of glucose-6-phosphate dehydrogenase (G6PD)-deficient erythrocytes parasitized by Plasmodium falciparum may explain malaria protection in G6PD deficiency. Blood 92: 2527-2534, 1998.
37. Castillo SS, Levy M, Wang CB, Thaikoottathil JV, Khan E, and Goldkorn T. Nitric oxide-enhanced caspase-3 and acidic sphingomyelinase interaction: A novel mechanism by which airway epithelial cells escape ceramide-induced apoptosis. Exp Cell Res 313: 816-823, 2007.
38. Charache S, Terrin ML, Moore RD, Dover GJ, Barton FB, Eckert SV, Mcmahon RP, Bonds DR, Orringer E, Jones S, Strayhorn D, Rosse W, Phillips G, Peace D, Johnsontelfair A, Milner P, Kutlar A, Tracy A, Ballas SK, Allen GE, Moshang J, Scott B, Steinberg M, Anderson A, Sabahi V, Pegelow C, Temple D, Case E, Harrell R, Childerie S, Embury S, Schmidt B, Davies D, Koshy M, Talischyzahed N, Dorn L, Pendarvis G, Mcgee M, Telfer M, Davis A, Castro O, Finke H, Perlin E, Siteman J, Gascon P, Dipaolo P, Gargiulo S, Eckman J, Bailey JH, Platt A, Waller L, Ramirez G, Knors V, Hernandez S, Rodriguez EM, Wilkes E, Vichinsky E, Claster S, Earles A, Kleman K, Mclaughlin K, Swerdlow P, Smith W, Maddox B, Usry L, Brenner A, Williams K, Obrien R, Genther K, Shurin S, Berman B, Chiarucci K, Keverline L, Olivieri N, Shaw D, Lewis N, Bridges K, Tynan B, Winograd C, Bellevue R, Dosik H, Sheikhai M, Ryans P, Souffrant H, Prchal J, Braddock J, Mcardle T, Carlos T, Schmotzer A, Gardner D, Moore R, Dover G, Bergner M, Ewart C, Eckert S, Lent C, Ulrich J, Fishpaw L, Tirado G, Gibson J, Moeller T, Nagel T, Terrin M, Handy C, Harris D, Canner M, Depkin J, Meinert N, Carroll M, Giro R, Karabelas S, Kelly C, Heyman M, Beilinson P, Druskin M, Ellis P, Flood WA, Kravitz S, Lanzkron S, Lorica V, Moliterno A, Nahum A, Nesbitt JA, Rosenthal L, Sharfman W, Streiff M, Wachsman M, Bray P, Vandang C, Casella J, Mcguire M, Patrick L, Schaad H, Steiner C, Johnson C, Bank A, Cutter G, Davis CE, Huntley O, Lessin L, Platt O, Graysecundy M, Bonds D, Reid C, Geller H, and Waclawiw M. Effect of Hydroxyurea on the Frequency of Painful Crises in Sickle-Cell-Anemia. New Engl J Med 332: 1317-1322, 1995.
39. Chirico EN and Pialoux V. Role of oxidative stress in the pathogenesis of sickle cell disease. IUBMB Life 64: 72-80, 2012.
40. Cho CS, Kato GJ, Yang SH, Bae SW, Lee JS, Gladwin MT, and Rhee SG. Hydroxyurea-induced expression of glutathione peroxidase 1 in red blood cells of individuals with sickle cell anemia. Antioxid Redox Signal 13: 1-11, 2010.
41. Cimen MY. Free radical metabolism in human erythrocytes. Clin Chim Acta 390: 1-11, 2008.
42. Cohen G and Hochstein P. Bringing an enzyme out of the closet-a citation-classic commentary on glutathioneperoxidase- the primary agent for the elimination of hydrogen-peroxide in erythrocytes. Curr Contents Life Sci 16: 9, 1991.
43. Damonte G, Guida L, Sdraffa A, Benatti U, Melloni E, Forteleoni G, Meloni T, Carafoli E, and De Flora A. Mechanisms of perturbation of erythrocyte calcium homeostasis in favism. Cell Calcium 13: 649-658, 1992.
44. Das A, Smolenski A, Lohmann SM, and Kukreja RC. Cyclic GMP-dependent protein kinase I alpha attenuates necrosis and apoptosis following ischemia/reoxygenation in adult cardiomyocyte. J Biol Chem 281: 38644-38652, 2006.
45. Dasgupta T, Fabry ME, and Kaul DK. Antisickling property of fetal hemoglobin enhances nitric oxide bioavailability and ameliorates organ oxidative stress in transgenic-knockout sickle mice. Am J Physiol Reg Int Comp Physiol 298: R394-R402, 2010.
46. Davidson SM and Duchen MR. Endothelial mitochondria- Contributing to vascular function and disease. Circulation Res 100: 1128-1141, 2007.
47. de Franceschi L, Turrini F, Honczarenko M, Ayi K, Rivera A, Fleming MD, Law T, Mannu F, Kuypers FA, Bast A, van der Vijgh WJ, and Brugnara C. In vivo reduction of erythrocyte oxidant stress in a murine model of beta-thalassemia. Haematologica 89: 1287-1298, 2004.
48. de Jong K, Emerson RK, Butler J, Bastacky J, Mohandas N, and Kuypers FA. Short survival of phosphatidylserineexposing red blood cells in murine sickle cell anemia. Blood 98: 1577-1584, 2001.
49. Dimmeler S, Haendeler J, Nehls M, and Zeiher AM. Suppression of apoptosis by nitric oxide via inhibition of interleukin-1 beta-converting enzyme (ICE)-like and cysteine protease protein (CPP)-32-like proteases. J Exp Med 185: 601-607, 1997.
50. Dmitrieva O, de Lusignan S, Macdougall IC, Gallagher H, Tomson C, Harris K, Desombre T, and Goldsmith D. Association of anaemia in primary care patients with chronic kidney disease: cross sectional study of quality improvement in chronic kidney disease (QICKD) trial data. BMC Nephrol 14: 24, 2013.
51. Dumaswala UJ, Wilson MJ, Wu YL, Wykle J, Zhuo L, Douglass LM, and Daleke DL. Glutathione loading prevents free radical injury in red blood cells after storage. Free Radic Res 33: 517-529, 2000.
52. Duranton C, Huber S, Tanneur V, Lang K, Brand V, Sandu C, and Lang F. Electrophysiological properties of the Plasmodium falciparum-induced cation conductance of human erythrocytes. Cell Physiol Biochem 13: 189-198, 2003.
53. Duranton C, Huber SM, and Lang F. Oxidation induces a Cl(-)-dependent cation conductance in human red blood cells. J Physiol 539: 847-855, 2002.
54. Eroglu S, Pandir D, Uzun FG, and Bas H. Protective role of vitamins C and E in diclorvos-induced oxidative stress in human erythrocytes in vitro. Biol Res 46: 33-38, 2013.
55. Facorro G, Aguirre F, Florentin L, Diaz M, De Paoli T, Ihlo JE, Hager AA, Sanchez Avalos JC, Farach HA, and Poole CP, Jr. Oxidative stress and membrane fluidity in erythrocytes from patients with hemolytic uremic syndrome. Acta Physiol Pharmacol Ther Latinoam 47: 137-146, 1997.
56. Fadok VA, Bratton DL, Rose DM, Pearson A, Ezekewitz RAB, and Henson PM. A receptor for phosphatidylserinespecific clearance of apoptotic cells. Nature 405: 85-90, 2000.
57. Felder KM, Hoelzle K, Ritzmann M, Kilchling T, Schiele D, Heinritzi K, Groebel K, and Hoelzle LE. Hemotrophic mycoplasmas induce programmed cell death in red blood cells. Cell Physiol Biochem 27: 557-564, 2011.
58. Firat U, Kaya S, Cim A, Buyukbayram H, Gokalp O, Dal MS, and Tamer MN. Increased caspase-3 immunoreactivity of erythrocytes in STZ diabetic rats. Exp Diabetes Res 2012: 316384, 2012.
59. Fischer K, Voelkl S, Berger J, Andreesen R, Pomorski T, and Mackensen A. Antigen recognition induces phosphatidylserine exposure on the cell surface of human CD8 + T cells. Blood 108: 4094-4101, 2006.
60. Foller M, Bobbala D, Koka S, Huber SM, Gulbins E, and Lang F. Suicide for survival-death of infected erythrocytes as a host mechanism to survive malaria. Cell Physiol Biochem 24: 133-140, 2009.
61. Foller M, Feil S, Ghoreschi K, Koka S, Gerling A, Thunemann M, Hofmann F, Schuler B, Vogel J, Pichler B, Kasinathan RS, Nicolay JP, Huber SM, Lang F, and Feil R. Anemia and splenomegaly in cGKI-deficient mice. Proc Natl Acad Sci U S A 105: 6771-6776, 2008.
62. Foller M, Harris IS, Elia A, John R, Lang F, Kavanagh TJ, and Mak TW. Functional significance of glutamate-cysteine ligase modifier for erythrocyte survival in vitro and in vivo. Cell Death Differ 20: 1350-1358, 2013.
63. Foller M, Kasinathan RS, Koka S, Lang C, Shumilina E, Birnbaumer L, Lang F, and Huber SM. TRPC6 contributes to the Ca(2 + ) leak of human erythrocytes. Cell Physiol Biochem 21: 183-192, 2008.
64. Foller M, Sopjani M, Koka S, Gu S, Mahmud H, Wang K, Floride E, Schleicher E, Schulz E, Munzel T, and Lang F. Regulation of erythrocyte survival by AMP-activated protein kinase. FASEB J 23: 1072-1080, 2009.
65. Foller M, Sopjani M, Mahmud H, and Lang F. Vanadateinduced suicidal erythrocyte death. Kidney Blood Press Res 31: 87-93, 2008.
66. Gaetani GF, Ferraris AM, Rolfo M, Mangerini R, Arena S, and Kirkman HN. Predominant role of catalase in the disposal of hydrogen peroxide within human erythrocytes. Blood 87: 1595-1599, 1996.
67. Gaetani GF, Galiano S, Canepa L, Ferraris AM, and Kirkman HN. Catalase and glutathione-peroxidase are equally active in detoxification of hydrogen-peroxide in human-erythrocytes. Blood 73: 334-339, 1989.
68. Galley HF. Oxidative stress and mitochondrial dysfunction in sepsis. Br J Anaesthesia 107: 57-64, 2011.
69. Gallo G, and Martino G. Red blood cell glutathione peroxidase activity in female nulligravid and pregnant rats. Reprod Biol Endocrinol 7: 7, 2009.
70. Ganesan S, Chaurasiya ND, Sahu R, Walker LA, and Tekwani BL. Understanding the mechanisms for metabolism- linked hemolytic toxicity of primaquine against glucose 6-phosphate dehydrogenase deficient human erythrocytes: evaluation of eryptotic pathway. Toxicology 294: 54-60, 2012.
71. Gao M, Cheung KL, Lau IP, Yu WS, Fung KP, Yu B, Loo JF, and Kong SK. Polyphyllin D induces apoptosis in human erythrocytes through Ca(2)( + ) rise and membrane permeabilization. Arch Toxicol 86: 741-752, 2012.
72. Gatidis S, Zelenak C, Fajol A, Lang E, Jilani K, Michael D, Qadri SM, and Lang F. p38 MAPK activation and function following osmotic shock of erythrocytes. Cell Physiol Biochem 28: 1279-1286, 2011.
73. Ghashghaeinia M, Cluitmans JC, Akel A, Dreischer P, Toulany M, Koberle M, Skabytska Y, Saki M, Biedermann T, Duszenko M, Lang F, Wieder T, and Bosman GJ. The impact of erythrocyte age on eryptosis. Br J Haematol 157: 606-614, 2012.
74. Ghashghaeinia M, Toulany M, Saki M, Bobbala D, Fehrenbacher B, Rupec R, Rodemann HP, Ghoreschi K, Rocken M, Schaller M, Lang F, and Wieder T. The NFkB pathway inhibitors Bay 11-7082 and parthenolide induce programmed cell death in anucleated Erythrocytes. Cell Physiol Biochem 27: 45-54, 2011.
75. Ginsburg H, and Atamna H. The redox status of malariainfected erythrocytes-an overview with an emphasis on unresolved problems. Parasite 1: 5-13, 1994.
76. Gitlin JD. Wilson disease. Gastroenterology 125: 1868-1877, 2003.
77. Gokkusu C, and Mostafazadeh T. Changes of oxidative stress in various tissues by long-term administration of vitamin E in hypercholesterolemic rats. Clin Chim Acta 328: 155-161, 2003.
78. Gomez SA, Abrey-Recalde MJ, Panek CA, Ferrarotti NF, Repetto MG, Mejias MP, Fernandez GC, Vanzulli S, Isturiz MA, and Palermo MS. The oxidative stress induced in vivo by Shiga toxin-2 contributes to the pathogenicity of haemolytic uraemic syndrome. Clin Exp Immunol 173: 463-472, 2013.
79. Gow AJ, Luchsinger BP, Pawloski JR, Singel DJ, and Stamler JS. The oxyhemoglobin reaction of nitric oxide. Proc Natl Acad Sci U S A 96: 9027-9032, 1999.
80. Grzelak A, Kruszewski M, Macierzynska E, Piotrowski L, Pulaski L, Rychlik B, and Bartosz G. The effects of superoxide dismutase knockout on the oxidative stress parameters and survival of mouse erythrocyt. Cell Mol Biol Lett 14: 23-34, 2009.
81. Haendeler J, Hoffmann J, Tischler V, Berk BC, Zeiher AM, and Dimmeler S. Redox regulatory and anti-apoptotic functions of thioredoxin depend on S-nitrosylation at cysteine 69. Nat Cell Biol 4: 743-749, 2002.
82. Haendeler J, Hoffmann J, Zeiher AM, and Dimmeler S. Antioxidant effects of statins via S-nitrosylation and activation of thioredoxin in endothelial cells-a novel vasculoprotective function of statins. Circulation 110: 856-861, 2004.
83. Haynes J, Obiako B, Hester RB, Baliga BS, and Stevens T. Hydroxyurea attenuates activated neutrophil-mediated sickle erythrocyte membrane phosphatidylserine exposure and adhesion to pulmonary vascular endothelium. Am J Physiol Hear Circ Physiol 294: H379-H385, 2008.
84. Haynes J, Obiako B, King JA, Hester RB, and Ofori-Acquah S. Activated neutrophil-mediated sickle red blood cell adhesion to lung vascular endothelium: role of phosphatidylserine-exposed sickle red blood cells. Am J Physiol Hear Circ Physiol 291: H1679-H1685, 2006.
85. Hermle T, Shumilina E, Attanasio P, Akel A, Kempe DS, Lang PA, Podolski M, Gatz S, Bachmann R, Bachmann C, Abele H, Huber S, Wieder T, and Lang F. Decreased cation channel activity and blunted channel-dependent eryptosis in neonatal erythrocytes. Am J Physiol Cell Physiol 291: C710-C717, 2006.
86. Hillery CA, Du MC, Wang WC, and Scott JP. Hydroxyurea therapy decreases the in vitro adhesion of sickle erythrocytes to thrombospondin and laminin. Br J Haematol 109: 322-327, 2000.
87. Hoffmann J, Haendeler J, Zeiher AM, and Dimmeler S. TNF alpha and oxLDL reduce protein S-nitrosylation in endothelial cells. J Biol Chem 276: 41383-41387, 2001.
88. Huber SM, Duranton C, and Lang F. Patch-clamp analysis of the "new permeability pathways" in malaria-infected erythrocytes. Int Rev Cytol 246: 59-134, 2005.
89. Huber SM, Uhlemann AC, Gamper NL, Duranton C, Kremsner PG, and Lang F. Plasmodium falciparum activates endogenous Cl(-) channels of human erythrocytes by membrane oxidation. EMBO J 21: 22-30, 2002.
90. Iuchi Y, Okada F, Takamiya R, Kibe N, Tsunoda S, Nakajima O, Toyoda K, Nagae R, Suematsu M, Soga T, Uchida K, and Fujii J. Rescue of anaemia and autoimmune responses in SOD1-deficient mice by transgenic expression of human SOD1 in erythrocytes. Biochem J 422: 313-320, 2009.
91. Jain SK. Presence of phosphatidylserine in the outer membrane bilayer of newborn human erythrocytes. Biochem Biophys Res Commun 136: 914-920, 1986.
92. Jain SK. Vitamin E and stabilization of membrane lipid organization in red blood cells with peroxidative damage. Biomed Biochim Acta 42: S43-S47, 1983.
93. Jilani K, Lupescu A, Zbidah M, Abed M, Shaik N, and Lang F. Enhanced apoptotic death of erythrocytes induced by the mycotoxin ochratoxin A. Kidney Blood Press Res 36: 107-118, 2012.
94. Jilani K, Lupescu A, Zbidah M, Shaik N, and Lang F. Withaferin A-stimulated Ca(2 + ) entry, ceramide formation and suicidal death of erythrocytes. Toxicol In Vitro 27: 52-58, 2013.
95. Joshi P and Gupta CM. Abnormal membrane phospholipid organization in Plasmodium falciparum-infected human erythrocytes. Br J Haematol 68: 255-259, 1988.
96. Kaestner L and Bernhardt I. Ion channels in the human red blood cell membrane: their further investigation and physiological relevance. Bioelectrochemistry 55: 71-74, 2002.
97. Kahn MJ, Maley JH, Lasker GF, and Kadowitz PJ. Updated role of nitric oxide in disorders of erythrocyte function. Cardiovasc Hematol Disord Drug Targets 13: 83-87, 2013.
98. Kamp D, Sieberg T, and Haest CWM. Inhibition and stimulation of phospholipid scrambling activity. Consequences for lipid asymmetry, echinocytosis, and microvesiculation of erythrocytes. Biochemistry 40: 9438-9446, 2001.
99. Kaul DK, Liu XD, Chang HY, Nagel RL, and Fabry ME. Effect of fetal hemoglobin on microvascular regulation in sickle transgenic-knockout mice. J Clin Invest 114: 1136-1145, 2004.
100. Kaul DK, Tsai HM, Liu XD, Nakada MT, Nagel RL, and Coller BS. Monoclonal antibodies to alpha V beta 3 (7E3 and LM609) inhibit sickle red blood cell-endothelium interactions induced by platelet-activating factor. Blood 95: 368-374, 2000.
101. Kean LS, Brown LE, Nichols JW, Mohandas N, Archer DR, and Hsu LL. Comparison of mechanisms of anemia in mice with sickle cell disease and beta-thalassemia: peripheral destruction, ineffective erythropoiesis, and phospholipid scramblase-mediated phosphatidylserine exposure. Exp Hematol 30: 394-402, 2002.
102. Kempe DS, Akel A, Lang PA, Hermle T, Biswas R, Muresanu J, Friedrich B, Dreischer P, Wolz C, Schumacher U, Peschel A, Gotz F, Doring G, Wieder T, Gulbins E, and Lang F. Suicidal erythrocyte death in sepsis. J Mol Med 85: 269-277, 2007.
103. Kempe DS, Lang PA, Duranton C, Akel A, Lang KS, Huber SM, Wieder T, and Lang F. Enhanced programmed cell death of iron-deficient erythrocytes. FASEB J 20: 368-370, 2006.
104. Kiefer CR and Snyder LM. Oxidation and erythrocyte senescence. Curr Opin Hematol 7: 113-116, 2000.
105. Kirk K. Membrane transport in the malaria-infected erythrocyte. Physiol Rev 81: 495-537, 2001.
106. Kirkman HN and Gaetani GF. Catalase-a tetrameric enzyme with 4 tightly bound molecules of NADPH. Proc Natl Acad Sci U S A 81: 4343-4347, 1984.
107. Klarl BA, Lang PA, Kempe DS, Niemoeller OM, Akel A, Sobiesiak M, Eisele K, Podolski M, Huber SM, Wieder T, and Lang F. Protein kinase C mediates erythrocyte "programmed cell death" following glucose depletion. Am J Physiol Cell Physiol 290: C244-C253, 2006.
108. Kobayashi S, Moriya H, Aso K, and Ohtake T. Vitamin Ebonded hemodialyzer improves atherosclerosis associated with a rheological improvement of circulating red blood cells. Kidney Int 63: 1881-1887, 2003.
109. Koka S, Foller M, Lamprecht G, Boini KM, Lang C, Huber SM, and Lang F. Iron deficiency influences the course of malaria in Plasmodium berghei infected mice. Biochem Biophys Res Commun 357: 608-614, 2007.
110. Koka S, Huber SM, Boini KM, Lang C, Foller M, and Lang F. Lead decreases parasitemia and enhances survival of Plasmodium berghei-infected mice. Biochem Biophys Res Commun 363: 484-489, 2007.
111. Koka S, Lang C, Boini KM, Bobbala D, Huber SM, and Lang F. Influence of chlorpromazine on eryptosis, parasitemia and survival of Plasmodium berghe infected mice. Cell Physiol Biochem 22: 261-268, 2008.
112. Koka S, Lang C, Niemoeller OM, Boini KM, Nicolay JP, Huber SM, and Lang F. Influence of NO synthase inhibitor L-NAME on parasitemia and survival of Plasmodium berghei infected mice. Cell Physiol Biochem 21: 481-488, 2008.
113. Kovesdy CP. Iron and clinical outcomes in dialysis and non-dialysis-dependent chronic kidney disease patients. Adv Chronic Kidney Dis 16: 109-116, 2009.
114. Kucherenko Y, Zelenak C, Eberhard M, Qadri SM, and Lang F. Effect of casein kinase 1alpha activator pyrvinium pamoate on erythrocyte ion channels. Cell Physiol Biochem 30: 407-417, 2012.
115. Kucherenko YV and Lang F. Inhibitory effect of furosemide on non-selective voltage-independent cation channels in human erythrocytes. Cell Physiol Biochem 30: 863-875, 2012.
116. Kumar A, Eckman JR, and Wick TM. Inhibition of plasma- mediated adherence of sickle erythrocytes to microvascular endothelium by conformationally constrained RGD-containing peptides. Am J Hematol 53: 92-98, 1996.
117. Kuypers FA, Yuan J, Lewis RA, Snyder LM, Kiefer CR, Bunyaratvej A, Fucharoen S, Ma L, Styles L, de Jong K, and Schrier SL. Membrane phospholipid asymmetry in human thalassemia. Blood 91: 3044-3051, 1998.
118. Kwack C and Balakrishnan VS. Managing erythropoietin hyporesponsiveness. Semin Dial 19: 146-151, 2006.
119. Lang E, Jilani K, Zelenak C, Pasham V, Bobbala D, Qadri SM, and Lang F. Stimulation of suicidal erythrocyte death by benzethonium. Cell Physiol Biochem 28: 347-354, 2011.
120. Lang E, Qadri SM, Jilani K, Zelenak C, Lupescu A, Schleicher E, and Lang F. Carbon monoxide-sensitive apoptotic death of erythrocytes. Basic Clin Pharmacol Toxicol 111: 348-355, 2012.
121. Lang E, Qadri SM, and Lang F. Killing me softly-suicidal erythrocyte death. Int J Biochem Cell Biol 44: 1236-1243, 2012.
122. Lang F, Busch GL, Ritter M, Volkl H, Waldegger S, Gulbins E, and Haussinger D. Functional significance of cell volume regulatory mechanisms. Physiol Rev 78: 247-306, 1998.
123. Lang F, Lang KS, Lang PA, Huber SM, and Wieder T. Mechanisms and significance of eryptosis. Antioxid Redox Signal 8: 1183-1192, 2006.
124. Lang F, Lang PA, Lang KS, Brand V, Tanneur V, Duranton C, Wieder T, and Huber SM. Channel-induced apoptosis of infected host cells-the case of malaria. Pflugers Arch 448: 319-324, 2004.
125. Lang KS, Duranton C, Poehlmann H, Myssina S, Bauer C, Lang F, Wieder T, and Huber SM. Cation channels trigger apoptotic death of erythrocytes. Cell Death Differ 10: 249-256, 2003.
126. Lang KS, Myssina S, Brand V, Sandu C, Lang PA, Berchtold S, Huber SM, Lang F, and Wieder T. Involvement of ceramide in hyperosmotic shock-induced death of erythrocytes. Cell Death Differ 11: 231-243, 2004.
127. Lang KS, Roll B, Myssina S, Schittenhelm M, Scheel-Walter HG, Kanz L, Fritz J, Lang F, Huber SM, and Wieder T. Enhanced erythrocyte apoptosis in sickle cell anemia, thalassemia and glucose-6-phosphate dehydrogenase deficiency. Cell Physiol Biochem 12: 365-372, 2002.
128. Lang PA, Beringer O, Nicolay JP, Amon O, Kempe DS, Hermle T, Attanasio P, Akel A, Schafer R, Friedrich B, Risler T, Baur M, Olbricht CJ, Zimmerhackl LB, Zipfel PF, Wieder T, and Lang F. Suicidal death of erythrocytes in recurrent hemolytic uremic syndrome. J Mol Med 84: 378-388, 2006.
129. Lang PA, Kaiser S, Myssina S, Wieder T, Lang F, and Huber SM. Role of Ca2 + -activated K+ channels in human erythrocyte apoptosis. Am J Physiol Cell Physiol 285: C1553-C1560, 2003.
130. Lang PA, Kasinathan RS, Brand VB, Duranton C, Lang C, Koka S, Shumilina E, Kempe DS, Tanneur V, Akel A, Lang KS, Foller M, Kun JF, Kremsner PG, Wesselborg S, Laufer S, Clemen CS, Herr C, Noegel AA, Wieder T, Gulbins E, Lang F, and Huber SM. Accelerated clearance of Plasmodium-infected erythrocytes in sickle cell trait and annexin-A7 deficiency. Cell Physiol Biochem 24: 415-428, 2009.
131. Lang PA, Kempe DS, Myssina S, Tanneur V, Birka C, Laufer S, Lang F, Wieder T, and Huber SM. PGE(2) in the regulation of programmed erythrocyte death. Cell Death Differ 12: 415-428, 2005.
132. Lang PA, Schenck M, Nicolay JP, Becker JU, Kempe DS, Lupescu A, Koka S, Eisele K, Klarl BA, Rubben H, Schmid KW, Mann K, Hildenbrand S, Hefter H, Huber SM, Wieder T, Erhardt A, Haussinger D, Gulbins E, and Lang F. Liver cell death and anemia in Wilson disease involve acid sphingomyelinase and ceramide. Nat Med 13: 164-170, 2007.
133. Lau IP, Chen H, Wang J, Ong HC, Leung KC, Ho HP, and Kong SK. In vitro effect of CTAB- and PEG-coated gold nanorods on the induction of eryptosis/erythroptosis in human erythrocytes. Nanotoxicology 6: 847-856, 2012.
134. Lee TH, Kim SU, Yu SL, Kim SH, Park DS, Moon HB, Dho SH, Kwon KS, Kwon HJ, Han YH, Jeong S, Kang SW, Shin HS, Lee KK, Rhee SG, and Yu DY. Peroxiredoxin II is essential for sustaining life span of erythrocytes in mice. Blood 101: 5033-5038, 2003.
135. Lew VL, Tiffert T, and Ginsburg H. Excess hemoglobin digestion and the osmotic stability of Plasmodium falciparum- infected red blood cells. Blood 101: 4189-4194, 2003.
136. Li JR and Billiar TR. The anti-apoptotic actions of nitric oxide in hepatocytes. Cell Death Differ 6: 952-955, 1999.
137. Low FM, Hampton MB, Peskin AV, and Winterbourn CC. Peroxiredoxin 2 functions as a noncatalytic scavenger of low-level hydrogen peroxide in the erythrocyte. Blood 109: 2611-2617, 2007.
138. Low FM, Hampton MB, and Winterbourn CC. Peroxiredoxin 2 and peroxide metabolism in the erythrocyte. Antioxid Redox Signal 10: 1621-1629, 2008.
139. Lupescu A, Jilani K, Zbidah M, and Lang F. Induction of apoptotic erythrocyte death by rotenone. Toxicology 300: 132-137, 2012.
140. Lupescu A, Shaik N, Jilani K, Zelenak C, Lang E, Pasham V, Zbidah M, Plate A, Bitzer M, Foller M, Qadri SM, and Lang F. Enhanced erythrocyte membrane exposure of phosphatidylserine following sorafenib treatment: an in vivo and in vitro study. Cell Physiol Biochem 30: 876-888, 2012.
141. Lutz HU. Innate immune and non-immune mediators of erythrocyte clearance. Cell Mol Biol (Noisy-le-grand) 50: 107-116, 2004.
142. Maellaro E, Leoncini S, Moretti D, Del Bello B, Tanganelli I, De Felice C, and Ciccoli L. Erythrocyte caspase-3 activation and oxidative imbalance in erythrocytes and in plasma of type 2 diabetic patients. Acta Diabetol 50: 489-495, 2013.
143. Malan D, Levi RC, Alloatti G, Marcantoni A, Bedendi I, and Gallo MP. Cyclic AMP and cyclic GMP independent stimulation of ventricular calcium current by peroxynitrite donors in guinea pig myocytes. J Cell Physiol 197: 284-296, 2003.
144. Mandal D, Baudin-Creuza V, Bhattacharyya A, Pathak S, Delaunay J, Kundu M, and Basu J. Caspase 3-mediated proteolysis of the N-terminal cytoplasmic domain of the human erythroid anion exchanger 1 (band 3). J Biol Chem 278: 52551-52558, 2003.
145. Mandal D, Moitra PK, Saha S, and Basu J. Caspase 3 regulates phosphatidylserine externalization and phagocytosis of oxidatively stressed erythrocytes. FEBS Lett 513: 184-188, 2002.
146. Manodori AB, Barabino GA, Lubin BH, and Kuypers FA. Adherence of phosphatidylserine-exposing erythrocytes to endothelial matrix thrombospondin. Blood 95: 1293-1300, 2000.
147. Matarrese P, Straface E, Pietraforte D, Gambardella L, Vona R, Maccaglia A, Minetti M, and Malorni W. Peroxynitrite induces senescence and apoptosis of red blood cells through the activation of aspartyl and cysteinyl proteases. FASEB J 19: 416-418, 2005.
148. Mavelli I, Ciriolo MR, Rossi L, Meloni T, Forteleoni G, De Flora A, Benatti U, Morelli A, and Rotilio G. Favism: a hemolytic disease associated with increased superoxide dismutase and decreased glutathione peroxidase activities in red blood cells. Eur J Biochem 139: 13-18, 1984.
149. Melino G, Bernassola F, Knight RA, Corasaniti MT, Nistico G, and FinazziAgro A. S-nitrosylation regulates apoptosis. Nature 388: 432-433, 1997.
150. Moore RB, Mankad MV, Shriver SK, Mankad VN, and Plishker GA. Reconstitution of Ca2 + -dependent K+ transport in erythrocyte-membrane vesicles requires a cytoplasmic protein. J Biol Chem 266: 18964-18968, 1991.
151. Myssina S, Huber SM, Birka C, Lang PA, Lang KS, Friedrich B, Risler T, Wieder T, and Lang F. Inhibition of erythrocyte cation channels by erythropoietin. J Am Soc Nephrol 14: 2750-2757, 2003.
152. Myssina S, Lang PA, Kempe DS, Kaiser S, Huber SM, Wieder T, and Lang F. Cl- channel blockers NPPB and niflumic acid blunt Ca(2 + )-induced erythrocyte
153. Nagababu E, Chrest FJ, and Rifkind JM. Hydrogenperoxide- induced heme degradation in red blood cells: the protective roles of catalase and glutathione peroxidase. Biochim Biophys Acta 1620: 211-217, 2003.
154. Nagababu E, Gulyani S, Earley CJ, Cutler RG, Mattson MP, and Rifkind JM. Iron-deficiency anaemia enhances red blood cell oxidative stress. Free Radic Res 42: 824-829, 2008.
155. Nagai-Kusuhara A, Nakamura M, Mukuno H, Kanamori A, Negi A, and Seigel GM. cAMP-responsive element binding protein mediates a cGMP/protein kinase G-deendent antiapoptotic signal induced by nitric oxide in retinal neuroglial progenitor cells. Exp Eye Res 84: 152-162, 2007.
156. Nagasaka H, Inoue I, Inui A, Komatsu H, Sogo T, Murayama K, Murakami T, Yorifuji T, Asayama K, Katayama S, Uemoto S, Kobayashi K, Takayanagi M, Fujisawa T, and Tsukahara H. Relationship between oxidative stress and antioxidant systems in the liver of patients with Wilson disease: hepatic manifestation in Wilson disease as a consequence of augmented oxidative stress. Pediatric Res 60: 472-477, 2006.
157. Necheles TF, Boles TA, and Allen DM. Erythrocyte glutathione-peroxidase deficiency and hemolytic disease of newborn infant. J Pediatrics 72: 319-324, 1968.
158. Nguyen DB, Wagner-Britz L, Maia S, Steffen P, Wagner C, Kaestner L, and Bernhardt I. Regulation of phosphatidylserine exposure in red blood cells. Cell Physiol Biochem 28: 847-856, 2011.
159. Nicolay JP, Liebig G, Niemoeller OM, Koka S, Ghashghaeinia M, Wieder T, Haendeler J, Busse R, and Lang F. Inhibition of suicidal erythrocyte death by nitric oxide. Pflugers Arch 456: 293-305, 2008.
160. Nicolay JP, Schneider J, Niemoeller OM, Artunc F, Portero-Otin M, Haik G, Jr., Thornalley PJ, Schleicher E, Wieder T, and Lang F. Stimulation of suicidal erythrocyte death by methylglyoxal. Cell Physiol Biochem 18: 223-232, 2006.
161. Nwose EU, Jelinek HF, Richards RS, and Kerr PG. Erythrocyte oxidative stress in clinical management of diabetes and its cardiovascular complications. Br J Biomed Sci 64: 35-43, 2007.
162. Ogasawara Y, Ohminato T, Nakamura Y, and Ishii K. Structural and functional analysis of native peroxiredoxin 2 in human red blood cells. Int J Biochem Cell Biol 44: 1072-1077, 2012.
163. Owusu BY, Stapley R, and Patel RP. Nitric oxide formation versus scavenging: the red blood cell balancing act. J Physiol Lond 590: 4993-5000, 2012.
164. Pacher P, Beckman JS, and Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev 87: 315-424, 2007.
165. Polak-Jonkisz D, and Purzyc L. Ca Influx versus Efflux during Eryptosis in Uremic Erythrocytes. Blood Purif 34: 209-210, 2012.
166. Qadri SM, Bauer J, Zelenak C, Mahmud H, Kucherenko Y, Lee SH, Ferlinz K, and Lang F. Sphingosine but not sphingosine-1-phosphate stimulates suicidal erythrocyte death. Cell Physiol Biochem 28: 339-346, 2011.
167. Qadri SM, Kucherenko Y, Zelenak C, Jilani K, Lang E, and Lang F. Dicoumarol activates Ca2 + -permeable cation channels triggering erythrocyte cell membrane scrambling. Cell Physiol Biochem 28: 857-864, 2011.
168. Qadri SM, Mahmud H, Lang E, Gu S, Bobbala D, Zelenak C, Jilani K, Siegfried A, Foller M, and Lang F. Enhanced suicidal erythrocyte death in mice carrying a loss-offunction mutation of the adenomatous polyposis coli gene. J Cell Mol Med 16: 1085-1093, 2012.
169. Qian EW, Ge DT, and Kong SK. Salidroside protects human erythrocytes against hydrogen peroxide-induced apoptosis. J Nat Prod 75: 531-537, 2012.
170. Raval JS, Fontes J, Banerjee U, Yazer MH, Mank E, and Palmer AF. Ascorbic acid improves membrane fragility and decreases haemolysis during red blood cell storage. Transfus Med 23: 87-93, 2013.
171. Rossig L, Fichtlscherer B, Breitschopf K, Haendeler J, Zeiher AM, Mulsch A, and Dimmeler S. Nitric oxide inhibits caspase-3 by S-nitrosation in vivo. J Biol Chem 274: 6823-6826, 1999.
172. Salhany JM. The oxidative denitrosylation mechanism and nitric oxide release from human fetal and adult hemoglobin, an experimentally based model simulation study. Blood Cells Molec Dis 50: 8-19, 2013.
173. Samuele A, Mangiagalli A, Armentero MT, Fancellu R, Bazzini E, Vairetti M, Ferrigno A, Richelmi P, Nappi G, and Blandini F. Oxidative stress and pro-apoptotic conditions in a rodent model of Wilson's disease. Biochim Biophys Acta 1741: 325-330, 2005.
174. Schwartz RS, Olson JA, Raventos-Suarez C, Yee M, Heath RH, Lubin B, and Nagel RL. Altered plasma membrane phospholipid organization in Plasmodium falciparuminfected human erythrocytes. Blood 69: 401-407, 1987.
175. Setty BN, Kulkarni S, Rao AK, and Stuart MJ. Fetal hemoglobin in sickle cell disease: relationship to erythrocyte phosphatidylserine exposure and coagulation activation. Blood 96: 1119-1124, 2000.
176. Setty BNY, Kulkarni S, Dampier CD, and Stuart MJ. Fetal hemoglobin in sickle cell anemia: relationship to erythrocyte adhesion markers and adhesion. Blood 97: 2568-2573, 2001.
177. Setty BNY, Kulkarni S, and Stuart MJ. Role of erythrocyte phosphatidylserine in sickle red cell-endothelial adhesion. Blood 99: 1564-1571, 2002.
178. Shaik N, Lupescu A, and Lang F. Sunitinib-sensitive suicidal erythrocyte death. Cell Physiol Biochem 30: 512-522, 2012.
179. Shaik N, Zbidah M, and Lang F. Inhibition of Ca(2 + ) entry and suicidal erythrocyte death by naringin. Cell Physiol Biochem 30: 678-686, 2012.
180. Sherman IW, Eda S, and Winograd E. Cytoadherence and sequestration in Plasmodium falciparum: defining the ties that bind. Microbes Infect 5: 897-909, 2003.
181. Sherman IW, Eda S, and Winograd E. Erythrocyte aging and malaria. Cell Mol Biol (Noisy-le-grand) 50: 159-169, 2004.
182. Sinet PM, Michelson AM, Bazin A, Lejeune J, and Jerome H. Increase in glutathione peroxidase-activity in erythrocytes from trisomy-21 subjects. Biochem Biophys Res Commun 67: 911-915, 1975.
183. Starzynski RR, Canonne-Hergaux F, Willemetz A, Gralak MA, Wolinski J, Stys A, Olszak J, and Lipinski P. Haemolytic anaemia and alterations in hepatic iron metabolism in aged mice lacking Cu, Zn-superoxide dismutase. Biochem J 420: 383-390, 2009.
184. Tanneur V, Duranton C, Brand VB, Sandu CD, Akkaya C, Kasinathan RS, Gachet C, Sluyter R, Barden JA, Wiley JS, Lang F, and Huber SM. Purinoceptors are involved in the induction of an osmolyte permeability in malaria-infected and oxidized human erythrocytes. FASEB J 20: 133-135, 2006.
185. Thornalley PJ. Modification of the glyoxalase system in human red blood cells by glucose in vitro. Biochem J 254: 751-755, 1988.
186. Turrini F, Ginsburg H, Bussolino F, Pescarmona GP, Serra MV, and Arese P. Phagocytosis of Plasmodium falciparum-infected human red blood cells by human monocytes: involvement of immune and nonimmune determinants and dependence on parasite developmental stage. Blood 80: 801-808, 1992.
187. Vos FE, Schollum JB, Coulter CV, Doyle TCA, Duffull SB, and Walker RJ. Red blood cell survival in long-term dialysis patients. Am J Kidney Dis 58: 591-598, 2011.
188. Vota DM, Crisp RL, Nesse AB, and Vittori DC. Oxidative stress due to aluminum exposure induces eryptosis which is prevented by erythropoietin. J Cell Biochem 113: 1581-1589, 2012.
189. Vota DM, Maltaneri RE, Wenker SD, Nesse AB, and Vittori DC. Differential erythropoietin action upon cells induced to eryptosis by different agents. Cell Biochem Biophys 65: 145-157, 2013.
190. Weil M, Jacobson MD, and Raff MC. Are caspases involved in the death of cells with a transcriptionally inactive nucleus? Sperm and chicken erythrocytes. J Cell Sci 111 (Pt 18): 2707-2715, 1998.
191. Weiss E, Cytlak UM, Rees DC, Osei A, and Gibson JS. Deoxygenation-induced and Ca(2 + ) dependent phosphatidylserine externalisation in red blood cells from normal individuals and sickle cell patients. Cell Calcium 51: 51-56, 2012.
192. William M, Vien J, Hamilton E, Garcia A, Bundgaard H, Clarke RJ, and Rasmussen HH. The nitric oxide donor sodium nitroprusside stimulates the Na + -K + pump in isolated rabbit cardiac myocytes. J Physiol Lond 565: 815-825, 2005.
193. Yang M, Fox CH, Vassalotti J, and Choi M. Complications of progression of CKD. Adv Chronic Kidney Dis 18: 400-405, 2011.
194. Yasin Z, Witting S, Palascak MB, Joiner CH, Rucknagel DL, and Franco RS. Phosphatidylserine externalization in sickle red blood cells: associations with cell age, density, and hemoglobin F. Blood 102: 365-370, 2003.
195. Zappulla D. Environmental stress, erythrocyte dysfunctions, inflammation, and the metabolic syndrome: adaptations to CO2 increases? J Cardiometab Syndr 3: 30-34, 2008.
196. Zbidah M, Lupescu A, Jilani K, and Lang F. Stimulation of Suicidal Erythrocyte Death by Fumagillin. Basic Clin Pharmacol Toxicol 112: 346-351, 2013.
197. Zelenak C, Eberhard M, Jilani K, Qadri SM, Macek B, and Lang F. Protein kinase CK1alpha regulates erythrocyte survival. Cell Physiol Biochem 29: 171-180, 2012.
198. Zelenak C, Foller M, Velic A, Krug K, Qadri SM, Viollet B, Lang F, and Macek B. Proteome analysis of erythrocytes lacking AMP-activated protein kinase reveals a role of PAK2 kinase in eryptosis. J Proteome Res 10: 1690-1697, 2011.
199. Zelenak C, Pasham V, Jilani K, Tripodi PM, Rosaclerio L, Pathare G, Lupescu A, Faggio C, Qadri SM, and Lang F. Tanshinone IIA stimulates erythrocyte phosphatidylserine exposure. Cell Physiol Biochem 30: 282-294, 2012.
200. Zhu Q, Sun Z, Jiang Y, Chen F, and Wang MF. Acrolein scavengers: Reactivity, mechanism and impact on health. Mol Nutr Food Res 55: 1375-1390, 2011.